Clinical Trials in Massachusetts

Showing 5981-6000 of 13,570 trials

Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

NCT04271501

Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.

Vitiligo

Avita Medical5 participantsStarted Sep 2020

Worcester, Massachusetts, United States

WITHDRAWNPhase 226 miles

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL

NCT05209308

A Phase 2 study of Zandelisib with Venetoclax (VEN) and Rituximab (R) in subjects with Relapsed/Refractory CLL.

CLL

MEI Pharma, Inc.Started Nov 2022

Boston, Massachusetts, United States • Stony Brook, New York, United States • Oklahoma City, Oklahoma, United States +1 more locations

COMPLETEDNA26 miles

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

NCT02919670

This research study is evaluating Enterade, a supplement, as a possible treatment for the side effects caused by Stem Cell Transplant. The following interventions will be involved in this study: * Enterade plus standard supportive care * Placebo plus standard supportive care. The placebo will be a mixture of water, electrolytes, and sweetener.

Multiple MyelomaNon-Hodgkin's Lymphoma

Dana-Farber Cancer Institute114 participantsStarted Oct 2016

Boston, Massachusetts, United States

Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Find Trials by Condition in Massachusetts

Vestibular Precision: Physiology & Pathophysiology

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

Optical Frequency Domain Imaging for Non-melanoma Skin Cancers

A Prospective Clinical Study of Phenylketonuria (PKU)

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients